Brenus Pharma, a Lyon-based clinical-stage biotech developing immunotherapy treatments to prevent cancer recurrence, has raised €11M in an extension of its Series A round, bringing total funding since founding to €38M.
Your go-to source for the latest Startup developments.
Would you like us to send you the latest news from the startup world?